BIO-TECHNE Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BIO-TECHNE Corp with three other
pharmaceutical manufacturers in North America:
Myriad Genetics Inc
sales of $851.10 million
of which 93%
Lannett Company, Inc.
of which 30%
was Thyroid Deficiency), and
Phibro Animal Health Corp
of which 64%
was Animal Health).
BIO-TECHNE Corp reported sales of $714.01 million
June of 2019.
increase of 11.0%
versus 2018, when the company's sales were $642.99 million.
Sales at BIO-TECHNE Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 100%).